BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study

NCT02550743 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped lack of accural

Conditions

Rectal Cancer

Interventions

DRUG: BYL719
DRUG: Capecitabine
RADIATION: Radiation

Sponsor

howard safran

Collaborators

[object Object]
[object Object]
[object Object]